Study Evaluating Bapineuzumab In Alzheimer Disease Subjects

Clinical trial NCT00663026 · COMPLETED

Trial details

NCT number: NCT00663026
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2008-11-01
Primary completion: 2010-10-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.